Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome
Open Access
- 28 October 2019
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 3 (21) , 3191-3195
Abstract
Key Points: One third of patients with USS have a neonatal episode of severe hemolytic jaundice with thrombocytopenia induced by an unknown trigger. A USS patient with persisting PDA and recurrent neonatal hemolysis/thrombocytopenia suggests blood flow through the PDA as trigger.Keywords
This publication has 21 references indexed in Scilit:
- Two newborn-onset patients of Upshaw–Schulman syndrome with distinct subsequent clinical coursesInternational Journal of Hematology, 2012
- From Clinical Observation to Mechanism — Heyde's SyndromeNew England Journal of Medicine, 2012
- Natural history of Upshaw–Schulman syndrome based on ADAMTS13 gene analysis in JapanJournal of Thrombosis and Haemostasis, 2011
- Platelets contribute to postnatal occlusion of the ductus arteriosusNature Medicine, 2009
- Novel monoclonal antibody‐based enzyme immunoassay for determining plasma levels of ADAMTS13 activityTransfusion, 2006
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Acquired von Willebrand Disease in an InfantThrombosis Research, 2001
- Congenital Deficiency of a Factor in Normal Plasma That Reverses Microangiopathic Hemolysis and ThrombocytopeniaNew England Journal of Medicine, 1978
- Thrombotic thrombocytopenic purpura in a neonatal infantThe Journal of Pediatrics, 1967